CME in the News and Blogs November 7th – 13th

November 16, 2009 at 7:04 pm Leave a comment

University of Miami hires controversial expert

The UM medical school hired a psychiatrist who has been criticized for taking millions of dollars from drugmakers.
Miami Herald, November 6th, 2009

Charles Nemeroff, an Atlanta psychiatrist who was the subject of a Senate investigation concerning huge sums he received from drug companies, has been named chairman of the psychiatry department at the University of Miami.

Last year Nemeroff, as the top psychiatrist at Emory University, was the focus of an investigation by Sen. Charles Grassley, R-Iowa, who said he was concerned about the millions the psychiatrist received from drug companies while conducting supposedly unbiased research for the National Institutes of Health on drugs made by the companies he was receiving money from.

Read More:

Are You Systematically Engaged in Performance Improvement in Your CME Operation?
Conversations n CME , November 8th, 2009

“Most CME providers I talk to are not engaged in a systematic, sustainable, repeatable effort to improve their own CME operation. What better place to learn how to develop improvement skills in our customers than to engage in improvement efforts in our own CME operation?”

Read More:

CME must be untainted — no matter who’s paying
American Medical News, Ethics Forum. November 9th 2009

Scenario: Should physicians pay for their own continuing medical education to avoid ethical entanglements?

“CME has long been subsidized by pharmaceutical companies and medical device manufacturers. Over the last decade, that funding source has generated increasingly intense ethical debate…………….”

“Has CME come to stand for commercial medical education? Many physicians recognize that the curriculum and content of continuing medical education are largely determined by those who pay for it.”

“We currently face a rather fierce debate on the question of who should own the CME agenda. No one would suggest that the only education physicians receive after leaving residency training should be in “product placement” or in understanding disease categories created to serve marketing needs. Yet many CME activities, as well as our professional associations, are heavily dependent on drug makers’ and device makers’ funding……………”

Read More:

AMA CEJA 2009: Report Financial Relationships with Industry in Continuing Medical Education Referred Back to Committee for the Third Time by AMA House of Delegates
Policy and Medicine, November 9th, 2009

“American Medical Association House of Delegates referred back to committee the Council on Judicial and Ethical Affairs report Financial Relationships with Industry in Continuing Medical Education referred to as CEJA 1. This is the third time it has been sent back for more work by the AMA House of Delegates.”

Read More:

Why is the American College of Rheumatology barring the media from adding CME? Medical Web Blog, November 9th, 2009
by Robert Stern, MA, CCMEP

“In our continuing saga with the American College of Rheumatology (ACR) and their oppressive media policies, one of our readers kindly forwarded a letter received by her from the president of the ACR who provides his justification for attempting to restrict MedPage Today’s access to their annual meeting.”

Read More:

Health-Bill Disclosure Rule Is Resisted
At Issue, Drug Makers’ Sponsorship of Doctors’ Continuing Education Classes

By Alicia Munday.
Wall Street Journal November 13th, 20029

“Health legislation moving through Congress would force drug makers to disclose how much they spend on continuing medical education classes for doctors, sparking some resistance from the industry. “

Read More:

How Industry Spends $1 Billion a Year on Continuing Medical Ed.

Wall Street Journal Health Blog by Alicia Munday, November 13th. 2009

“Drug and device companies, along with other industry players, spend about $1 billion a year to fund the continuing medical education classes doctors have to take to keep their licenses current. We may soon get more insight into how that money flows: A little-discussed provision in the House health care bill would require drug makers to disclose their spending on CME, the WSJ reports.

Sens. Herb Kohl and Chuck Grassley have been interested in this sort of thing for a while — and they’ve been the target of some critical blog posts by Tom Sullivan, the owner of a CME company called Rockpointe.

His blog caught the attention of Kohl’s Special Committee on Aging, which requested records of payments from the health-care industry to Sulllivan’s company. You can read the list for yourself — it adds up to more than $20 million since the start of 2006.”

Read More:

Tom Sullivan, of ACRE FAME, is Swimming in Drug Company Cash

The Carlat Psychiatry Blog, November 12, 2009

Wherever there is a vocal battalion of defenders of drug industry funded medical education, you are certain to find Tom Sullivan leading the charge. Sullivan writes the most prolific pro-industry CME website, Policy and Medicine. He is a founding member of ACRE, and managed all the logistics for ACRE’s first embarrassing meeting, held at Brigham and Women’s Hospital. He collaborates closely with John Kamp, director of the pro-commercial CME front group, Coalition for Healthcare Communication.

Read More:


Entry filed under: CME, CME Issues, Continuing Medical Education, Pharma Funding, Physician Continuing Education, Physician Education.

Are You Systematically Engaged in Performance Improvement in Your CME Operation? CME in the News and Blogs November 16th -21st

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


November 2009
« Oct   Dec »

Most Recent Posts

%d bloggers like this: